META

Meta Platforms, Inc.

65
Fundamentals60/ 100
Valuation67/ 100
Upside potential65/ 100
Risk potential18/ 100

META has slightly lower modeled downside risk, despite its lower overall score.

ORCL

Oracle Corporation

65
Fundamentals60/ 100
Valuation78/ 100
Upside potential73/ 100
Risk potential19/ 100

ORCL has a slight edge over META overall, supported by stronger valuation and stronger modeled upside.

META Fundamentals

MetricStatus
Healthy
Strong
Stable
Healthy

META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.

ORCL Fundamentals

MetricStatus
Healthy
Strong
Weak
Strong

ORCL's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.

META PE Valuation

CHEAPFAIREXPENSIVE10x20x30x40x
CHEAPFAIREXPENSIVE10x20x30x40x
LevelPEPriceVs current
Forward19x$624—
Cheap21x$613-1.7%
Current21x$624—
Fair27x$803+29%
Expensive32x$934+50%

Historical ranges are pointers, not guarantees.

META's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.

ORCL PE Valuation

CHEAPFAIREXPENSIVE19x37x56x74x
CHEAPFAIREXPENSIVE19x37x56x74x
LevelPEPriceVs current
Forward15x$127—
Cheap19x$119-6.8%
Current20x$127—
Fair30x$189+49%
Expensive39x$247+94%

Historical ranges are pointers, not guarantees.

ORCL has the edge over META in the historical PE scenario, which offers more potential upside but is not a forecast.

META Forward outlook

MetricOutlook
Improving
Growth
Strong growth
Strongly weakening
Moderate
Low

Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.

ORCL Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly weakening
Moderate
High

Analysts expect strong earnings and revenue growth for ORCL, but weaker profitability.

META Risk to reward

ScenarioChangePrice
Upside+33%$829.21
Downside-18%$513.25

Calculated from the latest close: $623.61 on Nov 12.

META trails ORCL on modeled risk to reward, with less potential upside relative to its potential downside.

ORCL Risk to reward

ScenarioChangePrice
Upside+52%$192.98
Downside-19%$102.46

Calculated from the latest close: $127.11 on Nov 12.

ORCL has a better modeled risk to reward balance than META, with more potential upside relative to its potential downside.

META Earnings Per Share

Q4 2023: $14.87Q1 2024: $17.38Q2 2024: $19.56Q3 2024: $21.20Q4 2024: $23.86Q1 2025: $25.58Q2 2025: $27.56Q3 2025: $22.58Q4 2025: $23.49Q1 2026: $27.50Q2 2026: $26.54Q3 2026: $29.32Forward: $32.16
Q4 2023: $14.87Q1 2024: $17.38Q2 2024: $19.56Q3 2024: $21.20Q4 2024: $23.86Q1 2025: $25.58Q2 2025: $27.56Q3 2025: $22.58Q4 2025: $23.49Q1 2026: $27.50Q2 2026: $26.54Q3 2026: $29.32Forward: $32.16
QuarterTTM EPSYoY
Forward$32.16+9.7%
Q3 2026$29.32+30%
Q2 2026$26.54-3.7%
Q1 2026$27.50+7.5%
Q4 2025$23.49-1.6%
Q3 2025$22.58+6.5%
Q2 2025$27.56+41%
Q1 2025$25.58+47%
Q4 2024$23.86+60%

META earned $29.32 per share over the past year, up 30% from the year before.

ORCL Earnings Per Share

Q4 2023: $3.63Q1 2024: $3.80Q2 2024: $3.71Q3 2024: $3.88Q4 2024: $4.09Q1 2025: $4.26Q2 2025: $4.34Q3 2025: $4.32Q4 2025: $5.32Q1 2026: $5.57Q2 2026: $5.83Q3 2026: $6.38Forward: $8.53
Q4 2023: $3.63Q1 2024: $3.80Q2 2024: $3.71Q3 2024: $3.88Q4 2024: $4.09Q1 2025: $4.26Q2 2025: $4.34Q3 2025: $4.32Q4 2025: $5.32Q1 2026: $5.57Q2 2026: $5.83Q3 2026: $6.38Forward: $8.53
QuarterTTM EPSYoY
Forward$8.53+34%
Q3 2026$6.38+48%
Q2 2026$5.83+34%
Q1 2026$5.57+31%
Q4 2025$5.32+30%
Q3 2025$4.32+11%
Q2 2025$4.34+17%
Q1 2025$4.26+12%
Q4 2024$4.09+13%

ORCL has the edge over META on earnings, with more consistent year-over-year improvement.

META Quarterly Revenue

Q4 2023: $40.1BQ1 2024: $36.5BQ2 2024: $39.1BQ3 2024: $40.6BQ4 2024: $48.4BQ1 2025: $42.3BQ2 2025: $47.5BQ3 2025: $51.2BQ4 2025: $59.9BQ1 2026: $56.3BQ2 2026: $60.8BQ3 2026: $64.6B
Q4 2023: $40.1BQ1 2024: $36.5BQ2 2024: $39.1BQ3 2024: $40.6BQ4 2024: $48.4BQ1 2025: $42.3BQ2 2025: $47.5BQ3 2025: $51.2BQ4 2025: $59.9BQ1 2026: $56.3BQ2 2026: $60.8BQ3 2026: $64.6B
QuarterRevenueYoY
Q3 2026$64.6B+26%
Q2 2026$60.8B+28%
Q1 2026$56.3B+33%
Q4 2025$59.9B+24%
Q3 2025$51.2B+26%
Q2 2025$47.5B+22%
Q1 2025$42.3B+16%
Q4 2024$48.4B+21%

META has the edge over ORCL on sales, with stronger typical year-over-year growth.

ORCL Quarterly Revenue

Q4 2023: $12.9BQ1 2024: $13.3BQ2 2024: $14.3BQ3 2024: $13.3BQ4 2024: $14.1BQ1 2025: $14.1BQ2 2025: $15.9BQ3 2025: $14.9BQ4 2025: $16.1BQ1 2026: $17.2BQ2 2026: $19.2BQ3 2026: $19.3B
Q4 2023: $12.9BQ1 2024: $13.3BQ2 2024: $14.3BQ3 2024: $13.3BQ4 2024: $14.1BQ1 2025: $14.1BQ2 2025: $15.9BQ3 2025: $14.9BQ4 2025: $16.1BQ1 2026: $17.2BQ2 2026: $19.2BQ3 2026: $19.3B
QuarterRevenueYoY
Q3 2026$19.3B+30%
Q2 2026$19.2B+21%
Q1 2026$17.2B+22%
Q4 2025$16.1B+14%
Q3 2025$14.9B+12%
Q2 2025$15.9B+11%
Q1 2025$14.1B+6.4%
Q4 2024$14.1B+8.6%

ORCL's revenue has grown year over year for 13 quarters in a row: $19.3B last quarter, up 30% from the same quarter a year ago.

META Free Cash Flow

Q4 2023: $11.7BQ1 2024: $12.8BQ2 2024: $11.2BQ3 2024: $16.5BQ4 2024: $13.6BQ1 2025: $11.1BQ2 2025: $9BQ3 2025: $11.2BQ4 2025: $14.8BQ1 2026: $13.2BQ2 2026: $1.7BQ3 2026: −$1.2B
Q4 2023: $11.7BQ1 2024: $12.8BQ2 2024: $11.2BQ3 2024: $16.5BQ4 2024: $13.6BQ1 2025: $11.1BQ2 2025: $9BQ3 2025: $11.2BQ4 2025: $14.8BQ1 2026: $13.2BQ2 2026: $1.7BQ3 2026: −$1.2B
QuarterFree cash flowYoY
Q3 2026-$1.2B-110%
Q2 2026$1.7B-81%
Q1 2026$13.2B+19%
Q4 2025$14.8B+9.3%
Q3 2025$11.2B-32%
Q2 2025$9B-19%
Q1 2025$11.1B-14%
Q4 2024$13.6B+16%

META has the edge over ORCL on cash generation, producing positive trailing cash flow while its opponent burns cash.

ORCL Free Cash Flow

Q4 2023: −$937MQ1 2024: $3.8BQ2 2024: $3.3BQ3 2024: $5.1BQ4 2024: −$2.7BQ1 2025: $71MQ2 2025: −$2.9BQ3 2025: −$362MQ4 2025: −$10BQ1 2026: −$11.5BQ2 2026: −$1.9BQ3 2026: −$5.4B
Q4 2023: −$937MQ1 2024: $3.8BQ2 2024: $3.3BQ3 2024: $5.1BQ4 2024: −$2.7BQ1 2025: $71MQ2 2025: −$2.9BQ3 2025: −$362MQ4 2025: −$10BQ1 2026: −$11.5BQ2 2026: −$1.9BQ3 2026: −$5.4B
QuarterFree cash flowYoY
Q3 2026-$5.4B-$5B
Q2 2026-$1.9B+$1.1B
Q1 2026-$11.5B-16275%
Q4 2025-$10B-$7.3B
Q3 2025-$362M-107%
Q2 2025-$2.9B-189%
Q1 2025$71M-98%
Q4 2024-$2.7B-$1.7B

ORCL has burned cash in seven of the last eight quarters: −$28.7B over the past year, against −$5.9B the year before.

META Total Shares

Q4 2023: 2.6BQ1 2024: 2.6BQ2 2024: 2.6BQ3 2024: 2.6BQ4 2024: 2.6BQ1 2025: 2.6BQ2 2025: 2.6BQ3 2025: 2.6BQ4 2025: 2.6BQ1 2026: 2.6BQ2 2026: 2.6BQ3 2026: 2.6B
Q4 2023: 2.6BQ1 2024: 2.6BQ2 2024: 2.6BQ3 2024: 2.6BQ4 2024: 2.6BQ1 2025: 2.6BQ2 2025: 2.6BQ3 2025: 2.6BQ4 2025: 2.6BQ1 2026: 2.6BQ2 2026: 2.6BQ3 2026: 2.6B
PeriodChange %Net change
Quarterly+0.3%+7M shares
1 year0%+1M shares
3 years-2.6%-68M shares
5 years-10%-286M shares
Available history-11%-303M shares

META has the edge over ORCL on shareholder dilution, with a more favorable share count trend.

ORCL Total Shares

Q4 2023: 2.8BQ1 2024: 2.8BQ2 2024: 2.8BQ3 2024: 2.9BQ4 2024: 2.9BQ1 2025: 2.9BQ2 2025: 2.9BQ3 2025: 2.9BQ4 2025: 2.9BQ1 2026: 2.9BQ2 2026: 2.9BQ3 2026: 3B
Q4 2023: 2.8BQ1 2024: 2.8BQ2 2024: 2.8BQ3 2024: 2.9BQ4 2024: 2.9BQ1 2025: 2.9BQ2 2025: 2.9BQ3 2025: 2.9BQ4 2025: 2.9BQ1 2026: 2.9BQ2 2026: 2.9BQ3 2026: 3B
PeriodChange %Net change
Quarterly+3%+86M shares
1 year+3.1%+91M shares
3 years+6.3%+177M shares
5 years+4.9%+139M shares
Available history-9.9%-331M shares

ORCL has 3B diluted shares, up 3.1% from a year ago.

META Net Leverage

Q4 2023: -0.4xQ1 2024: -0.2xQ2 2024: -0.2xQ3 2024: -0.2xQ4 2024: -0.2xQ1 2025: 0.0xQ2 2025: 0.2xQ3 2025: 0.2xQ4 2025: 0.2xQ1 2026: 0.3xQ2 2026: 0.6xQ3 2026: 0.7x
Q4 2023: -0.4xQ1 2024: -0.2xQ2 2024: -0.2xQ3 2024: -0.2xQ4 2024: -0.2xQ1 2025: 0.0xQ2 2025: 0.2xQ3 2025: 0.2xQ4 2025: 0.2xQ1 2026: 0.3xQ2 2026: 0.6xQ3 2026: 0.7x
QuarterNet LeverageStatus
Q3 20260.7xVery low
Q2 20260.6xVery low
Q1 20260.3xVery low
Q4 20250.2xVery low
Q3 20250.2xVery low
Q2 20250.2xVery low
Q1 20250.0xVery low
Q4 2024-0.2xNet Cash

META's net debt is less than a year of its operating earnings (EBITDA).

ORCL Net Leverage

Q4 2023: -0.1xQ1 2024: -0.2xQ2 2024: 4.1xQ3 2024: -0.1xQ4 2024: 0.2xQ1 2025: 0.2xQ2 2025: 3.7xQ3 2025: -0.1xQ4 2025: 0.3xQ1 2026: 0.5xQ2 2026: 3.5xQ3 2026: -0.9x
Q4 2023: -0.1xQ1 2024: -0.2xQ2 2024: 4.1xQ3 2024: -0.1xQ4 2024: 0.2xQ1 2025: 0.2xQ2 2025: 3.7xQ3 2025: -0.1xQ4 2025: 0.3xQ1 2026: 0.5xQ2 2026: 3.5xQ3 2026: -0.9x
QuarterNet LeverageStatus
Q3 2026-0.9xNet Cash
Q2 20263.5xElevated
Q1 20260.5xVery low
Q4 20250.3xVery low
Q3 2025-0.1xNet Cash
Q2 20253.7xElevated
Q1 20250.2xVery low
Q4 20240.2xVery low

ORCL has the edge over META on leverage, with a lower net debt burden relative to earnings.

META Weekly Momentum

MetricValueStatus
RSI48.2Neutral
Stochastic33.7Neutral

META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).

ORCL Weekly Momentum

MetricValueStatus
RSI41.9Neutral
Stochastic23.0Neutral

ORCL's weekly RSI is 42 (neutral) and its Stochastic is 23 (neutral).

META PE vs Communication Services Sector

MetricMETASector medianRelative
PE21x16x29% above
PE %18268 pts below

META is trading at 21x earnings, a 29% premium to the Communication Services sector's median of 16x.

ORCL PE vs Technology Sector

MetricORCLSector medianRelative
PE20x28x28% below
PE %28357 pts below

ORCL has the edge over META on valuation relative to its sector.

META Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$674.97.6% below
20 week MA$634.51.7% below
50 week MA$630.81.1% below
100 week MA$647.83.7% below
200 week MA$517.521% above

META has the edge over ORCL on trend strength, trading above more of its moving averages.

ORCL Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$131.13.1% below
20 week MA$137.67.7% below
50 week MA$160.321% below
100 week MA$181.430% below
200 week MA$151.916% below

ORCL is in a downtrend: it's below all five of its weekly moving averages, and 16% below its 200-week average.

META Yearly ROI

YearStart priceEnd priceROI
2020$208.1$267.4+28%
2021$267.4$335.2+25%
2022$335.2$118.0-65%
2023$118.0$354.0+200%
2024$354.0$599.8+69%
2025$599.8$663.3+11%
2026 YTD$663.3$623.6-6%

META has the edge over ORCL on returns for 2026, with the stronger performance.

ORCL Yearly ROI

YearStart priceEnd priceROI
2020$53.5$65.0+22%
2021$65.0$89.7+38%
2022$89.7$80.9-9.9%
2023$80.9$105.4+30%
2024$105.4$169.0+60%
2025$169.0$198.0+17%
2026 YTD$198.0$127.1-36%

ORCL is down 36% so far in 2026, after finishing higher in five of the previous six years.

Give your agent the market.

Get API key